DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC reduced its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 7.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 109,559 shares of the medical instruments supplier’s stock after selling 9,319 shares during the quarter. Mutual of America Capital Management LLC owned 0.05% of DENTSPLY SIRONA worth $2,965,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in XRAY. UMB Bank n.a. increased its holdings in shares of DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares during the period. Capital Performance Advisors LLP bought a new stake in DENTSPLY SIRONA during the third quarter worth approximately $27,000. LRI Investments LLC increased its position in shares of DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares during the period. Rothschild Investment LLC bought a new stake in shares of DENTSPLY SIRONA in the 2nd quarter worth $32,000. Finally, Kennebec Savings Bank acquired a new stake in shares of DENTSPLY SIRONA in the third quarter valued at $35,000. Institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several research reports. Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Evercore ISI dropped their target price on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, November 8th. Finally, Barrington Research cut their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Seven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average price target of $29.50.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $18.77 on Friday. The company’s fifty day moving average is $23.25 and its two-hundred day moving average is $25.09. The company has a market cap of $3.73 billion, a P/E ratio of -9.07, a price-to-earnings-growth ratio of 1.83 and a beta of 1.02. DENTSPLY SIRONA Inc. has a 12-month low of $17.21 and a 12-month high of $37.60. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. During the same period in the previous year, the firm earned $0.49 earnings per share. DENTSPLY SIRONA’s quarterly revenue was up .4% on a year-over-year basis. Equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.